Key facts
- This page summarizes DEERFIELD PARTNERS, L.P.'s Form 3 filing for Nuvalent, Inc. (NUVL).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Nov 2022, 17:23.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
SEC remarks
Each of Cameron Wheeler, a partner in Deerfield Management Company, L.P. (the investment manager to Deerfield Partners, L.P.), and Joseph Pearlberg, an employee of Deerfield Management Company, L.P., serves as a director of the Issuer. Jonathan Isler, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24 to a Form 4 with regard to DA32 Life Science Tech Acquisition Corp. filed with the Securities and Exchange Commission on August 3, 2021 by Deerfield Partners, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and James E. Flynn.